We use cookies for analytics and ads to improve your experience. You can accept or decline. See our Privacy Policy.
Unlisted shares are illiquid and carry higher risk than listed securities. Prices are indicative, not live. Read the risk disclosure.

Valuation
Investment Thesis
SNS Diagnostics Limited status is AMALGAMATED — merged into another entity. No financial filings since March 2019. Revenue was under ₹1 Cr (FY2016, FY2019). ISIN INE362S01018; authorized ₹5 Cr; paid-up ₹1.35 Cr. Room No. 106, 1st Floor, 2162/T-10A, Guru Arjun Nagar, New Delhi 110008. CIN: L74899DL1983PLC016371.
Pros
Cons
Business Segments
Diagnostics / Financial Services (Historical)
Historical diagnostics/pathology business; now classified under financial services; amalgamated — no independent operations. Delhi.
Revenue Model
Fee-for-service diagnostic testing charges. Based on available data, revenue is minimal (under Rs 1 Cr).
Detailed Analysis
Growth Plans
Growing demand for diagnostics services driven by Ayushman Bharat and other government health insurance schemes
Post-COVID awareness about preventive health checkups boosting industry volumes
Industry Tailwinds
Growing demand for diagnostics services driven by Ayushman Bharat and other government health insurance schemes
Post-COVID awareness about preventive health checkups boosting industry volumes
Recent Developments
SNS Diagnostics Limited's last AGM was in September 2019 and balance sheet was last filed for March 2019. No publicly available updates since then.
2019-2024Comparable Companies
LALPATHLAB · 18000 Cr
Frequently Asked Questions
About SNS Diagnostics
SNS Diagnostics Limited is a New Delhi-based diagnostics company incorporated on August 19, 1983, with CIN L74899DL1983PLC016371. The company operates in the medical diagnostics sector, providing laboratory testing and diagnostic services. Established over four decades ago in 1983, SNS Diagnostics was among the early organized diagnostics players in Delhi. The company has been registered at the Registrar of Companies, Delhi, under the public limited company category. Based on available MCA filings, SNS Diagnostics appears to have been either dormant or operating at minimal scale, with the last AGM held in September 2019 and balance sheet filed for March 2019. Revenue as reported in public databases is under Rs 1 crore, suggesting the company operates at minimal or near-dormant scale. Delhi's diagnostics market has transformed significantly since SNS Diagnostics' 1983 incorporation, with large organized players like Dr Lal PathLabs and Metropolis Healthcare dominating the space. Independent diagnostics companies of this vintage either expanded significantly, merged with larger networks, or wound down to minimal operations. SNS Diagnostics falls in the latter category based on publicly available information. Despite its limited current operational scale, the company's 40+ year history since 1983 reflects an era when independent pathology labs served local community healthcare needs. The diagnostics industry's consolidation trend has been driven by quality standardization requirements, NABL accreditation demands, and the emergence of pan-India diagnostics chains.
Key Milestones
Incorporated August 19, 1983 in Delhi (CIN: L74899DL1983PLC016371) — 42+ years old
Common questions about unlisted shares
You buy from and sell to the wisefolio desk — shares route through the desk's demat, money-in before shares-out.
You enquire
· Takes 2 minutesTell us the company and quantity you want. Share your demat details so we can settle directly into your account.
We source & quote
· Typically within 1 business dayOur desk sources the shares and comes back with a firm price and an allocation for the quantity available.
You accept the allocation
· Quote valid for 3 daysReview the price, quantity and total. Accept to lock the allocation. The quote is valid for a short window before it needs re-pricing.
You transfer the funds
· Pay within 2 days of acceptingPay by direct bank transfer to the desk's published account — never to a personal account. We confirm receipt and begin the transfer.
Shares reach your demat
· Usually credited within 2–3 business daysOnce payment is verified, the shares are transferred from the desk's demat into yours, and you receive a transfer confirmation.
A principal desk for unlisted & pre-IPO shares — you transact with us, not a stranger.
You enquire
Takes 2 minutes
We source & quote
Typically within 1 business day
You accept the allocation
Quote valid for 3 days
You transfer the funds
Pay within 2 days of accepting
Shares reach your demat
Usually credited within 2–3 business days
Unlisted shares are illiquid and carry higher risk. Pricing is indicative, not live, and these are private off-market transactions with no exchange settlement guarantee. Read the full risk disclosure.
Be the first to discuss SNS Diagnostics — share your research, ask questions, or compare notes with other investors.
Industry Headwinds
Dominant position of large diagnostic chains with extensive networks and brand recognition
Possible dormancy or shell company risk given share price at face value
Last MCA compliance filing was for FY2019 — no recent filings suggests dormant or non-compliant status
Source: Regulatory Filings
Share price at face value of ₹10 suggests possible dormancy or very limited active business operations
Diagnostics sector dominated by large organized chains like Dr Lal PathLabs, Metropolis Healthcare, SRL Diagnostics, and Thyrocare, making it difficult for smaller players to compete
No publicly available website or detailed company information limits transparency for potential investors
Medical diagnostics subject to NABL accreditation, ICMR guidelines, and state health regulations
METROPOLIS · 7000 Cr
THYROCARE · 3000 Cr
ISIN INE362S01018; revenue under ₹1 Cr (FY2016, FY2019); no filings since March 2019
Status: AMALGAMATED — merged into another entity; no independent operations remaining